The unwarranted use of replicate analysis in routine coagulation studies

Quality assurance in coagulation testing is a critical concern in clinical diagnostics. Prior research has shown that semiautomated coagulation methods are widely used in routine laboratories. However, the role of replicate testing in improving test reliability remains unclear. Some laboratories implement duplicate assays as a precautionary measure. Others rely on standard quality control protocols instead. No prior work had resolved whether replicate testing adds measurable value. This uncertainty drove the need for a systematic evaluation. The study aimed to clarify whether replicate analysis improves accuracy and precision. The findings could inform standard operating procedures in coagulation labs.

This study aimed to evaluate whether replicate testing improves the accuracy and precision of routine coagulation assays. The focus was on prothrombin time (PT) and activated partial thromboplastin time (aPTT) measurements. These tests are essential for monitoring anticoagulant therapy. The researchers sought to determine if duplicate assays are necessary. They compared results from two different photo-optical detection systems. The goal was to assess whether replicate testing reduces variability. The study also examined the impact of plasma volume on test outcomes. The findings could guide quality assurance practices in clinical labs.

The researchers conducted duplicate PT and aPTT assays on 60 plasma specimens. Each sample was tested in three plasma volumes: 80, 100, and 140 microL. Two distinct photo-optical detection systems were used for comparison. A total of 1,440 individual tests were performed across all conditions. The study design allowed for the evaluation of inter-system variability. No external variables were introduced to alter the testing environment. Statistical analysis focused on differences between replicate results. The researchers assessed precision and accuracy using standard metrics.

The study found no statistically significant differences between replicate PT and aPTT results. Variability across the two detection systems was also not significant. Plasma volume did not affect the consistency of the measurements. The results suggest that duplicate testing does not improve precision. Accuracy remained stable regardless of the number of replicates. The researchers observed no benefit from running duplicate assays. The findings indicate that quality assurance procedures are more effective. These include calibration checks, internal standards, and commercial controls.

The authors concluded that replicate analysis does not enhance the precision or accuracy of routine coagulation studies. The study supports the use of standard quality assurance measures instead. These include frequent calibration checks and the use of internal standards. The findings suggest that duplicate testing is unnecessary in most cases. The researchers propose that laboratories can rely on established protocols. No evidence was found to support the routine use of replicate assays. The results align with the goal of optimizing laboratory efficiency. The study does not suggest changes to current quality control practices.